相关实验视频

Updated: Jun 14, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

药物涂层气球基复血管化的影响,慢性全闭症患者

Eun-Seok Shin¹, Ae-Young Her², Mi Hee Jang¹

¹Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Republic of Korea.

Journal of clinical medicine

|June 27, 2024

概括

基于药物涂层气球 (DCB) 的通皮冠状动脉干预 (PCI) 治疗慢性全闭 (CTO) 减少了支架使用和主要不良心血管事件 (MACE). 这种DCB方法为CTO病变提供了一种更安全的替代方案,而不是仅用于DES的PCI.

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学
医疗器械中的生物材料

背景情况:

药物排泄支架 (DES) 改善了慢性冠状动脉全封闭 (CTO) 的结果,但药物涂层气球 (DCB) 的数据有限.
CTO PCI旨在改善症状和生活质量.

研究的目的:

为了在CTO病变中比较基于DCB的PCI与仅DES的PCI的疗效和安全性.
在2年随访时评估主要不良心血管事件 (MACE).

主要方法:

一项对200名以DCB为基础的PCI (单独使用DCB或使用DES) 治疗的患者和661名仅使用DES的PCI治疗的患者进行比较研究.
主要终点是MACEs,包括心脏死亡,心肌梗塞,血栓形成,再血管和严重出血.

主要成果:

基于DCB的PCI使用的支架较少 (1.0与2.0,p<0.001) 和较短的长度 (6.5mm与42.0mm,p<0.001).
在DCB组中观察到小支架 (≤2.5mm) 的使用率较低 (9.8% vs 36.5%,p < 0.001).
2年后,在基于DCB的PCI组中,MACE显著降低 (3.1%对13.2%,p=0.001).

结论:

在CTO病变中,基于DCB的PCI显著降低了支架负担,特别是小直径支架.
这种方法与MACEs的风险较低,而与DES-only PCI相比.

关键词:

气球血管整形术气球血管整形术冠状动脉疾病是一种冠状动脉疾病.用药物涂层的气球.药物释放的支架可以释放药物.通过皮肤进行冠状动脉干预.

更多相关视频

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock

Published on: May 19, 2022

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...